Marc C. Gittelman

Current position(s)

• URO-Care, URO-MEDIX - Founder, Co-Medical Director and Urologist, Miami, FL,

Past position(s)

• South Florida Medical Research - Executive Director and CEO, Aventura, FL
• University of Miami - Assistant Professor of Medicine, Miami, FL

Universities

• Tufts University, BS, Biology, Medford, MA
• Mount Sinai School of Medicine, New York, NY

Internships

• Mount Sinai Medical Center, General Surgery, New York, NY

Residencies

• Mount Sinai Medical Center, Urology, Chief Resident, New York, NY

• Benign Prostatic Hyperplasia (BPH)
• Prostate Health
• Prostate Cancer
• Sexual Health for Men
• Erectile Dysfunction
• Low Testosterone
• Sexual Health issues for Women
• Kidney Stones
• Urinary Tract Infections
• Voiding and Leakage Problems

• Phi Beta Kappa and summa cum laude at Tufts University
• Alpha Omega Alpha Medical Honor Society
• Sigma Xi Research Society
• Anna Quincy Churchill Prize for General Biology

• A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men.
• Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
• Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study

• Response and Rebuttal to Editorial Commentary on "Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study"
• A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
• An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device. View publication